ESR1 and breast cancer: Despite its antiviral properties, BCA2 has been associated with breast cancer development, since this protein is found overexpressed in over 50% invasive breast cancers, and its up-regulation correlates with estrogen receptor positive (ER+) status and poor prognosis (Burger et al., 2005, 2010).